Posts in tag

biosimilars


Video 1: Michelle Leech: Bolstering patient confidence through collaborative care Professor Michelle Leech, Head of the Rheumatoid Arthritis Clinic at Monash Health, Victoria, explains the importance of bolstering patient confidence through …

Rheumatologist, Dr Gerald Tracey explains the opportunities biosimilars present for prescribing physicians, particularly given the government supported streamlined process. Gerald highlights the advantages of collaborative care between the prescriber and …

Trent Twomey, the National President of the Pharmacy Guild of Australia highlights the shifting power dynamic from physicians to patients in determining what medicines they are prescribed. Collaborative care is …

Professor Andrew Oster, Consultant Rheumatologist at the Cabrini Medical Centre in Malvern, Victoria, explains the opportunities biosimilars bring, allowing patients to switch medications. Given the interchangeability of biosimilars, he emphasises …

Head of Pharmacy at Blooms The Chemist, Eric Chan emphasises the importance of collaborative care in cultivating a relationship of trust and transparency between a pharmacist and physician. He outlines …

Professor Michelle Leech, Head of the Rheumatoid Arthritis Clinic at Monash Health, Victoria, explains the importance of bolstering patient confidence through collaborative care. Displaying this combined physician and pharmacist approach …

George Tambassis, Pharmacist, ex-National Guild President, and chair of the Australian Biosimilar Academy Advisory Board outlines the importance of pharmacist involvement in understanding biosimilars. Given the government supported Community Pharmacy …

Up until now, most biosimilars have been in the domain of public and private hospitals, however the release shortly of biosimilar adalimumab, which is currently a self-administered subcutaneous injection, means …

Biosimilars and the pharmacist’s role in their supply remains controversial, writes Carlene McMaugh Biological pharmaceutical products have been a part of the landscape of therapeutics for a number of years …

Here’s what you need to know While there are not many biosimilars available yet in Australia, several have been added to the ARTG and PBS this year. Biosimilar medicines are …

A recent survey found that pharmacist comfort with supplying biosimilars is going backward, so what can be done to turn this around? In 2018, 361 community pharmacists were surveyed across …

Pharmacists’ authority to use their expertise to substitute one medicine for another should also apply to biological medicines, says FIP The International Pharmaceutical Federation has published a revised Statement of …